ZME Science on MSN1d
A Simple Blood Test Called PAC-MANN Could Detect Pancreatic Cancer Early and Save Thousands of LivesPancreatic cancer is one of the deadliest and most difficult-to-detect forms of cancer. It kills nearly half a million people ...
ExtremeTech on MSN11d
Blood Test Helps Diagnose Early-Stage Pancreatic Cancer With 85% AccuracyPaired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of ...
Early-stage pancreatic cancer can be identified thanks to a newly developed blood test which offers up to 85% accuracy in ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...
GlobalData on MSN1d
Tumour-on-chip model could help discover pancreatic cancer therapiesA team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ...
The study developed a noninvasive detection method based on serum protease activity, leveraging the increased protease activity in the peripheral blood of patients with PDAC. Researchers screened a ...
Read more at about DURIPANC at ClinicalTrials.gov NCT05927142 – “Combining anti-PD-L1 immune checkpoint inhibitor durvalumab ...
In a recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98% specificity and 73% sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback